Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 24 03:53PM ET
239.52
Dollar change
-1.00
Percentage change
-0.41
%
IndexS&P 500 P/E49.28 EPS (ttm)4.86 Insider Own0.14% Shs Outstand290.39M Perf Week-0.33%
Market Cap69.23B Forward P/E16.70 EPS next Y14.34 Insider Trans-2.08% Shs Float288.63M Perf Month1.84%
Income1.41B PEG6.16 EPS next Q3.77 Inst Own89.94% Short Float0.86% Perf Quarter0.94%
Sales19.83B P/S3.49 EPS this Y7.38% Inst Trans2.65% Short Ratio1.92 Perf Half Y3.92%
Book/sh89.50 P/B2.68 EPS next Y9.36% ROA2.69% Short Interest2.48M Perf Year-7.59%
Cash/sh18.47 P/C12.97 EPS next 5Y8.00% ROE5.63% 52W Range218.75 - 262.23 Perf YTD-1.77%
Dividend Est.3.75 (1.56%) P/FCF21.49 EPS past 5Y52.43% ROI3.21% 52W High-8.66% Beta0.43
Dividend TTM3.80 (1.59%) Quick Ratio1.36 Sales past 5Y4.86% Gross Margin42.06% 52W Low9.50% ATR (14)3.50
Dividend Ex-DateSep 09, 2024 Current Ratio1.85 EPS Y/Y TTM-12.17% Oper. Margin12.86% RSI (14)51.86 Volatility1.20% 1.47%
Employees73000 Debt/Eq0.75 Sales Y/Y TTM4.11% Profit Margin7.13% Recom1.55 Target Price277.31
Option/ShortYes / Yes LT Debt/Eq0.70 EPS Q/Q23.24% Payout73.72% Rel Volume0.41 Prev Close240.52
Sales Surprise-0.39% EPS Surprise5.79% Sales Q/Q2.30% EarningsNov 07 BMO Avg Volume1.29M Price239.52
SMA20-0.01% SMA500.94% SMA2001.29% Trades Volume522,712 Change-0.41%
Date Action Analyst Rating Change Price Target Change
Oct-01-24Upgrade Citigroup Neutral → Buy $255 → $275
May-30-24Initiated Goldman Buy $274
Jul-24-23Upgrade Raymond James Mkt Perform → Outperform $305
May-30-23Resumed Morgan Stanley Overweight $295
May-05-23Upgrade Piper Sandler Neutral → Overweight $260 → $290
Apr-12-23Upgrade KeyBanc Capital Markets Sector Weight → Overweight $304
Jan-03-23Upgrade BofA Securities Neutral → Buy $250 → $290
Dec-12-22Upgrade Citigroup Sell → Neutral $221 → $250
Jul-11-22Downgrade Citigroup Neutral → Sell $265 → $235
Jun-24-22Upgrade Wells Fargo Equal Weight → Overweight $275
Oct-22-24 12:45PM
Oct-15-24 05:07AM
Oct-14-24 09:40AM
06:45AM
Oct-11-24 12:10PM
09:45AM Loading…
09:45AM
Oct-10-24 07:21PM
04:15PM
Oct-07-24 09:50AM
Oct-03-24 05:05PM
Oct-02-24 05:00PM
08:40AM
Sep-26-24 06:50AM
Sep-25-24 04:05PM
Sep-18-24 06:50AM
09:40AM Loading…
Sep-10-24 09:40AM
Sep-09-24 09:45AM
Sep-04-24 05:32AM
Sep-03-24 04:30PM
04:30PM
Aug-23-24 09:45AM
Aug-22-24 01:00PM
09:40AM
Aug-21-24 09:50AM
Aug-15-24 10:57AM
Aug-13-24 03:01PM
Aug-12-24 06:50AM
Aug-08-24 04:15PM
07:00AM
Aug-06-24 04:20PM
01:04AM Loading…
Aug-03-24 01:04AM
Aug-01-24 01:43PM
12:57PM
09:30AM
07:45AM
06:39AM
06:30AM
Jul-30-24 05:30AM
Jul-29-24 12:17PM
09:16AM
Jul-25-24 06:45AM
Jul-23-24 04:15PM
12:00PM
Jul-19-24 08:58AM
Jul-16-24 12:19PM
Jul-11-24 03:45PM
Jul-10-24 12:12PM
06:50AM
Jul-05-24 12:08PM
Jul-04-24 04:12AM
Jul-03-24 08:30AM
Jul-01-24 06:00AM
Jun-27-24 12:51PM
Jun-26-24 06:45AM
Jun-22-24 07:27AM
07:20AM
Jun-20-24 08:30AM
Jun-10-24 07:01AM
Jun-06-24 02:31PM
02:25PM
Jun-05-24 12:18PM
Jun-04-24 04:45AM
Jun-03-24 04:30PM
02:13PM
11:58AM
11:34AM
08:25AM
06:30AM
06:30AM
May-21-24 04:30PM
May-17-24 12:27PM
May-15-24 10:57AM
06:45AM
May-06-24 10:51AM
06:51AM
May-03-24 11:39AM
07:08AM
03:01AM
01:07AM
May-02-24 10:26PM
02:16PM
01:59PM
10:54AM
09:40AM
09:30AM
09:25AM
09:15AM
08:48AM
07:52AM
07:40AM
07:25AM
07:18AM
06:41AM
06:30AM
May-01-24 03:00PM
Apr-30-24 04:15PM
Apr-29-24 04:15PM
12:21PM
09:16AM
Apr-26-24 06:00AM
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BURZIK CATHERINE MDirectorSep 16 '24Proposed Sale235.7840094,312Sep 16 11:52 AM
Goette RolandEVP and President EMEAAug 14 '24Option Exercise132.545,295701,79916,603Aug 15 01:47 PM
Spoerel Thomas JSVP,Controller&Chief Acct OffJun 10 '24Sale239.3130071,7931,976Jun 11 01:45 PM
Goette RolandEVP and President EMEAMay 15 '24Sale236.733,300781,22411,308May 16 07:54 PM
Goette RolandEVP and President EMEAMay 13 '24Sale236.703,300781,12114,608May 15 02:44 PM
Garrison Michael DavidEVP & President MedicalApr 30 '24Sale232.811,715399,2695,381May 01 12:59 PM
Spoerel Thomas JSVP,Controller&Chief Acct OffMar 14 '24Sale238.2928267,1982,276Mar 15 02:19 PM
Garrison Michael DavidEVP & President MedicalDec 11 '23Sale232.461,239288,0187,274Dec 12 04:31 PM
Byrd RichardEVP & President InterventionalNov 28 '23Sale238.472,156514,1414,120Nov 29 07:27 PM
Goette RolandEVP and President, EMEANov 16 '23Option Exercise107.123,544379,63317,164Nov 20 02:20 PM